Development of robust artificial neural networks for prediction of 5-year survival in bladder cancer

被引:21
|
作者
Bhambhvani, Hriday P. [1 ]
Zamora, Alvaro [2 ]
Shkolyar, Eugene [1 ]
Prado, Kris [1 ]
Greenberg, Daniel R. [1 ]
Kasman, Alex M. [1 ]
Liao, Joseph [1 ]
Shah, Sumit [3 ]
Srinivas, Sandy [3 ]
Skinner, Eila C. [1 ]
Shah, Jay B. [1 ]
机构
[1] Stanford Univ, Med Ctr, Dept Urol, Stanford, CA 94305 USA
[2] Stanford Univ, Dept Phys, Stanford, CA 94305 USA
[3] Stanford Univ, Med Ctr, Div Med Oncol, Stanford, CA 94305 USA
关键词
Survival; Cystectomy; 5-year; Urothelial; Carcinoma; RADICAL CYSTECTOMY; RECURRENCE; RISK;
D O I
10.1016/j.urolonc.2020.05.009
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Purpose: When exploring survival outcomes for patients with bladder cancer, most studies rely on conventional statistical methods such as proportional hazards models. Given the successful application of machine learning to handle big data in many disciplines outside of medicine, we sought to determine if machine learning could be used to improve our ability to predict survival in bladder cancer patients. We compare the performance of artificial neural networks (ANN), a type of machine learning algorithm, with that of multivariable Cox proportional hazards (CPH) models in the prediction of 5-year disease-specific survival (DSS) and overall survival (OS) in patients with bladder cancer. Subjects and methods: The National Cancer Institute's Surveillance, Epidemiology, and End Results (SEER) 18 program database was queried to identify adult patients with bladder cancer diagnosed between 1995 and 2010, yielding 161,227 patients who met our inclusion criteria. ANNs were trained and tested on an 80/20 split of the dataset. Multivariable CPH models were developed in parallel. Variables used for prediction included age, sex, race, grade, SEER stage, tumor size, lymph node involvement, degree of extension, and surgery received. The primary outcomes were 5-year DSS and 5-year OS. Receiver operating characteristic curve analysis was conducted, and ANN models were tested for calibration. Results: The area under the curve for the ANN models was 0.81 for the OS model and 0.80 for the DSS model. Area under the curve for the CPH models was 0.70 for OS and 0.81 for DSS. The ANN OS model achieved a calibration slope of 1.03 and a calibration intercept of - 0.04, while the ANN DSS model achieved a calibration slope of 0.99 and a calibration intercept of - 0.04. Conclusions: Machine learning algorithms can improve our ability to predict bladder cancer prognosis. Compared to CPH models, ANNs predicted OS more accurately and DSS with similar accuracy. Given the inherent limitations of administrative datasets, machine learning may allow for optimal interpretation of the complex data they contain. (C) 2020 Elsevier Inc. All rights reserved.Y
引用
收藏
页码:193.e7 / 193.e12
页数:6
相关论文
共 50 条
  • [21] Design and Development of an Intelligent System for Predicting 5-Year Survival in Gastric Cancer
    Afrash, Mohammad Reza
    Shanbehzadeh, Mostafa
    Kazemi-Arpanahi, Hadi
    CLINICAL MEDICINE INSIGHTS-ONCOLOGY, 2022, 16
  • [22] Precise Prediction of 5-Year Survival of Lung Cancer Patients after Radical Surgery
    Kshivets, Oleg
    JOURNAL OF THORACIC ONCOLOGY, 2015, 10 (09) : S556 - S556
  • [23] Artificial intelligence-based 5-year survival prediction and prognosis of DNp73 expression in rectal cancer patients
    Pham, Tuan D.
    Fan, Chuanwen
    Zhang, Hong
    Sun, Xiao-Feng
    CLINICAL AND TRANSLATIONAL MEDICINE, 2020, 10 (04):
  • [24] Artificial Neural Networks in Cancer Recurrence Prediction
    Ritthipravat, Panrasee
    2009 INTERNATIONAL CONFERENCE ON COMPUTER ENGINEERING AND TECHNOLOGY, VOL II, PROCEEDINGS, 2009, : 103 - 107
  • [25] Survival prediction using artificial neural networks in patients with lung cancer treated by radiotherapy
    Iinuma, M
    Teshima, T
    Iwanaga, Y
    Kawamata, M
    Nagayoshi, M
    Murase, K
    CARS 2002: COMPUTER ASSISTED RADIOLOGY AND SURGERY, PROCEEDINGS, 2002, : 1011 - 1011
  • [26] Development and external validation of a risk-prediction model to predict 5-year overall survival in advanced larynx cancer
    Petersen, Japke F.
    Stuiver, Martijn M.
    Timmermans, Adriana J.
    Chen, Amy
    Zhang, Hongzhen
    O'Neill, James P.
    Deady, Sandra
    Vander Poorten, Vincent
    Meulemans, Jeroen
    Wennerberg, Johan
    Skroder, Carl
    Day, Andrew T.
    Koch, Wayne
    van den Brekel, Michiel W. M.
    LARYNGOSCOPE, 2018, 128 (05): : 1140 - 1145
  • [27] Assessment of 5-year overall survival in bladder cancer patients with incidental prostate cancer identified at radical cystoprostatectomy
    Wu, Shulin
    Lin, Sharron X.
    Lu, Min
    Subtelny, Alexander O.
    Wang, Zongwei
    Dahl, Douglas M.
    Olumi, Aria F.
    Wu, Chin-Lee
    INTERNATIONAL UROLOGY AND NEPHROLOGY, 2019, 51 (09) : 1527 - 1535
  • [28] Chemoradiotherapy for Muscle-invasive Bladder Cancer; 5-year Survival Outcomes, the Edinburgh Cancer Centre Experience
    Parry, J.
    Doyle, E.
    Curran, O.
    Law, A.
    McLaren, D.
    Malik, J.
    CLINICAL ONCOLOGY, 2024, 36 (01) : E82 - E83
  • [29] Assessment of 5-year overall survival in bladder cancer patients with incidental prostate cancer identified at radical cystoprostatectomy
    Shulin Wu
    Sharron X. Lin
    Min Lu
    Alexander O. Subtelny
    Zongwei Wang
    Douglas M. Dahl
    Aria F. Olumi
    Chin-Lee Wu
    International Urology and Nephrology, 2019, 51 : 1527 - 1535
  • [30] FALLACY OF 5-YEAR SURVIVAL IN LUNG-CANCER
    MCNEIL, BJ
    WEICHSELBAUM, R
    PAUKER, SG
    NEW ENGLAND JOURNAL OF MEDICINE, 1978, 299 (25): : 1397 - 1401